Why Lanthanein Resources (ASX:LNR) more than doubled on December 6 2023

Nick Sundich Nick Sundich, December 6, 2023

Lanthanein Resources (ASX:LNR), an ASX small cap explorer focused on rare earths, rose after signing a farm-in agreement, but not the typical kind you may think. Typically farm in agreements involve a major miner coming to the table to prospect at the smaller company’s project. In this instance, it is Lanthanein that has initiated a farm-in agreement, and it also may mark a change in direction for the company.

 

Lanthanein Resources (ASX:LNR) share price chart, log scale (Source: TradingView)

 

Lanthanein Resources pivoting to lithium

Lanthanein told investors it entered into a transaction to earn up to a 70% interest in the Lady Grey Lithium Project. This is 365km east of Perth and is directly adjacent to the nearby Earl Gray Mine. This operation has a resource of 189MT @ 1.53% lithium and is co-operated by SQM and Wesfarmers. And Lanthanein has not just been granted a small tenure, it has obtained 77km with ~18km of strike.

 

So now what?

Lanthanein told investors it would begin a drilling program in the first quarter of next year. It has an approved program for 193 Aircore and 53 RC (Reverse Circulation) drillholes, along with an extensive soil geochemistry program across other targets. There are also heritage approvals for expanded drill programs.

If the program is successful, there could be more upside in this one. However, as it is with all early stage explorers, shareholders can do nothing more at this stage than keep their fingers crossed.

 

What are the Best ASX Stocks to invest in right now?

Check our ASX buy/sell tips

 

Blog Categories

Get Our Top 5 ASX Stocks for FY26

Recent Posts

Prescient Therapeutics

Prescient Therapeutics (ASX:PTX): Its taken the plunge into a Phase 2 trial against T-Cell Lymphoma

There’s plenty of ASX oncology biotechs conducting clinical trials, but Prescient Therapeutics (ASX:PTX) is one of the closest to commercialisation.…

Botanix Pharmaceuticals

Botanix Pharmaceuticals (ASX:BOT): Did it deserve to crash over 50% earlier this week?

Botanix Pharmaceuticals (ASX:BOT) crashed over 50% back on Tuesday after an update that left investors disappointed. A crash of this…

beat the market

How can an investor beat the market? Here’s how to go about it

You may’ve heard the expression to ‘beat the market’. What does this mean? Well, it depends on the context in…